4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrah

Details 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrah 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrah

1988-08-29

1990-10-16

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5142332, 544117, 544281, A61K 31495, C07D48704

Patent

active

049635530

ABSTRACT:
Novel compounds of the formula ##STR1## wherein n is an integer from 1 to 4 inclusive; R.sub.1 represents a mono- or disubstituent or hydrogen, lower alkyl(C.sub.1 -C.sub.3), lower alkoxy(C.sub.1 -C.sub.3), halogen, nitro or trifluoromethyl; R.sub.2 is cyano, carboxamido, ethyl carboxylate or halogen; R.sub.3 is hydrogen, straight or branched chain lower alkyl(C.sub.1 -C.sub.3), alkenyl(C.sub.2 -c.sub.3), alkynyl(C.sub.2 -c.sub.3), cycloalkyl(C.sub.3 -C.sub.6), hydroxyalkyl(C.sub.1 -C.sub.3), dimethylaminoalkyl(C.sub.1 -C.sub.3), ethoxycarbonyl, alkyl(C.sub.1 -C.sub.13)carbonyl, 1-(methylethyl)acetamide, cyclohexylethyl, phenyl, mono-or disubstituted phenyl (wherein the phenyl substituent is halogen, trifluoromethyl, lower alkyl(C.sub.1 -C.sub.3) or lower alkoxy(C.sub.1 -C.sub.3)), benzyl, mono- or disubstituted benzyl (wherein the benzyl substituent is halogen, lower alkyl(C.sub.1 -C.sub.3), lower alkoxy(C.sub.1 -C.sub.3) or trifluoromethyl), benzoyl, 4-methoxybenzoyl, straight or branched chain alkyl(C.sub.2 -c.sub.3)phenyl, (4-chlorophenyl)phenylmethyl, 1,3-benzodioxol-5-ylmethyl, 1,3-benzodioxol-5-yl, 2-furanylcarbonyl, 2-pyrimidinyl, 2-pyridinyl, 4-morpholinyl-2-oxoethyl, 1-pyrrolidinyl-2-oxoethyl, bis(4-fluorophenyl(methyl, phenylcarboxamido, mono- and disubstituted phenylcarboximido (wherein the phenyl substituents is halogen, trifluoromethyl or lower alkyl(c.sub.1 -C.sub.3)), adamantanoyl, 3-phenoxypropyl, 4[2-[(5-chloro-2-methoxyphenyl)amino-2-oxo-ethyl], (2-oxo-1-pyrrolidinyl-2-butynyl, phenylmethylcarboxylate, or (2-phenyl-2H-1,2,3-triazol-4-yl(methyl; R.sub.4 and R.sub.5 are independently hydrogen or lower alkyl(C.sub.1 -C.sub.3); the dotted line between positions 6 and 7 of the pyrimidine ring represents the presence or absence of a double bond; and the pharmacologically acceptable salts thereof: methods of producing them; therapeutic compositions containing them: and methods of using them to treat anxiety, hypertension, depression, senile dementia, cognitive defects and other neutral behavior problems in warm-blooded animals.

REFERENCES:
patent: 4448962 (1984-05-01), Irikura et al.
patent: 4847256 (1989-07-01), Tseng et al.

Affiliated with

Also associated with

Rating

4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrah does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrah, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrah will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-850054